2xp2
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | [[Image:2xp2.png|left|200px]] | |
| - | [[Image:2xp2. | + | |
<!-- | <!-- | ||
| Line 12: | Line 11: | ||
===STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)=== | ===STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21812414}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21812414 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21812414}} | ||
==About this Structure== | ==About this Structure== | ||
| - | + | [[2xp2]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XP2 OCA]. | |
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:021812414</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
[[Category: Brooun, A.]] | [[Category: Brooun, A.]] | ||
| - | [[Category: Cui, J.]] | + | [[Category: Cui, J J.]] |
[[Category: Deng, Y.]] | [[Category: Deng, Y.]] | ||
[[Category: Liu, W.]] | [[Category: Liu, W.]] | ||
| Line 26: | Line 34: | ||
[[Category: Crizotinib]] | [[Category: Crizotinib]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 15 10:46:50 2010'' | ||
Revision as of 04:48, 28 September 2011
STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)
Template:ABSTRACT PUBMED 21812414
About this Structure
2xp2 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Cui JJ, Tran-Dube M, Shen H, Nambu M, Kung PP, Pairish M, Jia L, Meng J, Funk L, Botrous I, McTigue M, Grodsky N, Ryan K, Padrique E, Alton G, Timofeevski S, Yamazaki S, Li Q, Zou H, Christensen J, Mroczkowski B, Bender S, Kania RS, Edwards MP. Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK). J Med Chem. 2011 Sep 22;54(18):6342-6363. Epub 2011 Aug 18. PMID:21812414 doi:10.1021/jm2007613
